Author: sHq_LoGiNz

PHOENIX, Aug. 12, 2025 /PRNewswire/ — After weeks of epic outdoor adventures, nationwide support, and an inspiring show of community spirit, the 2025 Jr. Ranger Competition has officially crowned its champion, awarding a $20,000 prize and a feature in Ranger Rick magazine. Hosted by Emmy-winning wildlife expert Jeff Corwin and powered by Colossal, the nation’s leading professional fundraiser, this year’s campaign raised an incredible $6,590,165, benefiting the National Wildlife Federation (NWF) to further fuel their mission to protect wildlife and wild places for generations to come.

“The Jr. Ranger Competition proves that when communities come together, amazing things happen—not just for the champions, but for the causes we believe in,” said Mary Hagen, Colossal CEO. “Raising over $6.5 million for the National Wildlife Federation means more wild places protected, more wildlife thriving, and more young people inspired to be stewards of the planet.”

Champion’s Spotlight
This year’s Jr. Ranger Champion, Thomas, is a nature-loving explorer who maps trails, hunts mushrooms, and helps keep beaches clean. He’s passionate about orcas, forest critters, discovering new sea life, beach cleanup, and conservation. Along with his $20,000 prize, Thomas will appear in an upcoming issue of Ranger Rick—the beloved children’s magazine published by the National Wildlife Federation that has inspired a love of wildlife in kids since 1967.

Runner-Up Recognition
The Jr. Ranger Runner-Up, Callan, is a budding naturalist who enjoys hiking, skiing with his grandpa, and exploring every corner of the outdoors. His curiosity about bugs, lizards, and all things dinosaur reflects the spirit of the Jr. Ranger competition: fostering wonder, discovery, and a commitment to protecting the planet.

A Mission That Matters
This year’s remarkable fundraising grant will help the National Wildlife Federation continue its decades-long mission to protect wildlife and wild places, ensuring that the next generation has the opportunity to explore, learn, and grow in the great outdoors.

About the National Wildlife Federation
Founded in 1936, the National Wildlife Federation is America’s largest conservation organization, uniting all Americans to ensure wildlife thrive in a rapidly changing world. The NWF works to protect and restore wildlife habitats, safeguard clean water, and connect people with nature. Learn more at nwf.org.

About Colossal
Colossal is a nationally registered professional fundraiser that inspires people to advocate for themselves and those in need. Through online competitions like Jr. Ranger, participants have the opportunity to make their mark while also making a big impact. Colossal competitions serve as fundraising campaigns for DTCare, a United States 501(c)(3) public charity organization, which then grants donation funds to specified charities at the completion of the competitions. Learn more at colossal.org. Who’s Next?

Media Contact:
pr@colossal.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/6-59-million-raised-for-the-national-wildlife-federation-as-2025-jr-ranger-champion-is-crowned-302528272.html

SOURCE COLOSSAL

Hosted by James Nevin, Partner at Brayton Purcell LLP, the Series Shines a Light on a Preventable Crisis Sweeping the Industry

NOVATO, Calif., Aug. 12, 2025 /PRNewswire/ — A groundbreaking new podcast, From Dust to Verdict, is launching to expose today’s most devastating and underreported occupational health crises: accelerated silicosis in artificial stone countertop fabrication workers. Hosted by James Nevin, a leading voice on occupational health litigation and a partner at Brayton Purcell LLP, the series serves as both an educational platform and a call to action.

A Modern Epidemic Rooted in Ancient History
Silicosis, an historically progressive and usually chronic lung disease, has long plagued workers exposed to silica dust. In the debut episodes, Nevin traces its origins from the slaves who built Egypt’s pyramids to the 1930s Hawks Nest disaster in West Virginia. Now, it’s back with a vengeance this time as an accelerated fatal disease in young workers —allegedly fueled by the rise of artificial (or engineered) stone slabs, replacing natural stone as the countertop material of choice – beautiful, affordable, and according to published peer-reviewed medical science, deadly for workers who fabricate the artificial stone slabs into the countertops installed in our homes and commercial buildings.

Unlike natural materials like granite (which contains ~45% silica), artificial stone contains up to 95% silica, in nano-sized particles that lodge deep in the lungs when inhaled during fabrication. Workers cutting, polishing, or drilling these materials are unknowingly inhaling toxic silica dust, even when using traditional safety measures like wet cutting or N95 masks.

Nevin explains how published studies by institutions like UCLA, Georgia Tech, Safe Work Australia, and OSHA reveal that silica dust levels during artificial stone fabrication routinely exceed legal thresholds, even with controls in place. These findings have confirmed what many attorneys, doctors, and worker advocates already feared: this is not just a public health threat—it’s a full-blown epidemic.

Inside the Episodes
Each episode of From Dust to Verdict dives deep into the multi-layered dimensions of this crisis:

• Episode 1: The Engineered Stone Epidemic – Serves as an introduction to From Dust to Verdict, outlining the podcast’s mission, the emerging crisis of artificial stone accelerated silicosis, and what listeners can expect from upcoming episodes focused on worker health, legal accountability, and the dangers of artificial stone.
• Episode 2: The Hidden Dangers of Artificial Stone – Details alleged industry failures to warn and protect workers, even as countries like Australia implement bans.
• Episode 3: Understanding Silicosis –Explains how respirable crystalline silica (RCS) causes disease, with workers progressing from mild to fatal forms in a matter of months.
• Episode 4: The Hierarchy Controls – Will discuss the various fabrication worker protections, such as wet equipment and masks, and why they are claimed to not be effective.

Beyond Silicosis: A Web of Related Diseases
Silicosis isn’t the only danger. Exposure during artificial stone fabrication is also linked to:
– Lung cancer
– Chronic kidney disease
– Autoimmune disorders (e.g., rheumatoid arthritis)
– COPD
– Sarcoidosis and tuberculosis, often misdiagnosed in these workers

Legal Rights, Safety, and Global Accountability
Future episodes of From Dust to Verdict will explore:

– Medical access: occupational specialists and programs like Medi-Cal
– Legal avenues: lawsuits, workers’ comp, statutes of limitation
– Industry accountability and global comparisons
– Worker stories and innovations for a safer future

A Voice for the Voiceless
From Dust to Verdict isn’t just about awareness—it’s about accountability. Through in-depth storytelling, expert interviews, scientific analysis, and legal insight, the podcast challenges listeners to confront the systems that allowed this crisis to grow unchecked.

“These are preventable tragedies,” said Nevin. “We’re talking about young workers—fathers, sons, brothers—being slowly suffocated by a product that shouldn’t be on the market in its current form. The science is clear. The lawsuits are underway. It’s time for action.”

About the Host
James Nevin is a trial attorney and partner at Brayton Purcell LLP, a law firm nationally recognized for its advocacy in toxic exposure and occupational disease litigation. Nevin has represented thousands of workers exposed to hazardous materials and has become a leading voice in the legal battle against artificial stone manufacturers.

About Brayton Purcell LLP
Brayton Purcell LLP is one of the country’s preeminent plaintiffs’ law firms, with over 40 years of experience in occupational disease litigation. With offices in Northern California, Southern California, Oregon, Utah, Colorado, and New Hampshire, and affiliated local counsel in numerous other states, the firm has successfully handled thousands of complex cases involving asbestos, artificial stone silicosis, toxic exposure, and catastrophic workplace injury.

Listen Now
From Dust to Verdict is available on all major podcast platforms, including YouTube, Spotify, Apple Podcasts, and iHeart Radio. New episodes are released bi-weekly. For more information, visit www.braytonlaw.com/podcast or follow @braytonlaw on social media.

For media inquiries or to speak with James Nevin or another representative from Brayton Purcell LLP, please contact:
Brayton Purcell LLP
(800) 598-0314
www.braytonlaw.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-podcast-from-dust-to-verdict-exposes-the-hidden-epidemic-of-accelerated-silicosis-among-artificial-stone-fabrication-workers-302528223.html

SOURCE Brayton Purcell LLP

NORWALK, Conn., Aug. 12, 2025 /PRNewswire/ — Terex Corporation (NYSE: TEX) today announced that it has completed a re-pricing of its term loan that is expected to reduce its cash interest costs by approximately $3 million annually.

“We are pleased to announce the re-pricing which increases the efficiency of our capital structure,” said Jennifer Kong-Picarello, Terex Senior Vice President and Chief Financial Officer. “Our term loan rate will now be S+175bps, improving by 25bps what was already an attractive rate.”

About Terex 
Terex Corporation is a global industrial equipment manufacturer of materials processing machinery, waste and recycling solutions, mobile elevating work platforms (MEWPs), and equipment for the electric utility industry. We design, build, and support products used in maintenance, manufacturing, energy, minerals and materials management, construction, waste and recycling, and the entertainment industry. We provide best-in-class lifecycle support to our customers through our global parts and services organization, and offer complementary digital solutions, designed to help our customers maximize their return on their investment. Certain Terex products and solutions enable customers to reduce their impact on the environment including electric and hybrid offerings that deliver quiet and emission-free performance, products that support renewable energy, and products that aid in the recovery of useful materials from various types of waste. Our products are manufactured in North America, Europe, and Asia Pacific and sold worldwide. For more information, please visit www.terex.com.

Contact Information
Derek Everitt
VP Investor Relations
Email: InvestorRelations@Terex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/terex-announces-re-pricing-of-term-loan-302525302.html

SOURCE Terex Corporation

With Three-Year Revenue Growth of 81 Percent, This Marks Air₂O’s First Time on the List 

NEW YORK, Aug. 12, 2025 /PRNewswire/ — Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Phoenix, Arizona based Air₂O is No. 4235 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia.  

Mike Sullivan, Air₂O CEO, remarked, “This first-time recognition by Inc. is another validation that our business strategy, investments in operations, and, as importantly, our employees to help energize their contributions are significant to our growth and success. Our culture is the primary driver that allows our company to be positioned for continued opportunities to provide custom thermal management solutions for our mission-critical clients in data centers, lithium-ion battery, and semiconductor industries.” 

This year’s Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market. Among the top 500 companies on the list, the median three-year revenue growth rate reached 1,552 percent, and those companies have collectively added more than 48,678 jobs to the U.S. economy over the past three years.  

For the full list, company profiles, and a searchable database by industry and location, visit: www.inc.com/inc5000.  

“Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company’s tenacity and clarity of vision,” says Mike Hofman, editor-in-chief of Inc. “These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn’t just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy.” 

Inc. will celebrate the honorees at the 2025 Inc. 5000 Conference & Gala, taking place October 22–24 in Phoenix, and the top 500 will be listed in the Fall issue of Inc. magazine. 

Sullivan continued, “It was indeed an excellent year with over 81% revenue growth. We are expanding our operations fivefold by moving into a larger facility this fall/winter. Named one of Arizona’s Most Admired Companies and honored as the Arizona Small Company Innovator of the Year in 2024, Air2O will continue to focus on delivering exceptional value to its customers, employees, and community as one of the state’s premier industrial design, engineering, and manufacturing firms.” 

Methodology  
Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons.  

About Inc. 
Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com. 

About Air₂O
Phoenix-based Air₂O, a subsidiary of the Eren Groupe, is a global leader in advanced thermal management solutions, particularly suited to the environmental and HVAC requirements of large-scale industrial facilities, including data centers, semiconductor manufacturing, lithium-ion battery production, and indoor agriculture. Our innovative, state-of-the-art systems are precisely calibrated to regulate temperature, humidity, dew point, and more in mission-critical facilities. With expert design, engineering, and custom-build capabilities, Air₂O delivers the world’s most efficient and sustainable thermal management solutions. Learn more at https://air2o.com 

CONTACT:
Al Maag
602-363-6038
al.maag@maagcommplus.com
More about Inc. and the Inc. 5000

View original content:https://www.prnewswire.com/news-releases/air2o-ranks-no-4235-on-the-2025-inc-5000-list-of-americas-fastest-growing-private-companies-302528157.html

SOURCE Air2O

NASHVILLE, Tenn., Aug. 12, 2025 /PRNewswire/ — pH-D Feminine Health, announces it has initiated the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial cleared to proceed by the U.S. Food and Drug Administration (FDA) to clinically validate boric acid suppositories as a potential treatment of yeast infections, with the intent to support submission of a New Drug Application (NDA).

This pivotal study marks a critical milestone in bringing clinical clarity to boric acid suppositories (BAS).

“By sponsoring this pivotal clinical trial, we’re taking the lead to generate the scientific evidence women deserve,” said Deeannah Seymour, co-founder and CEO of pH-D Feminine Health. “This trial marks a decisive step toward providing boric acid for therapeutic use to women through rigorous research and regulatory alignment. Our mission has always been clear: advance the science, honor the data, and make affordable, accessible solutions available to every woman who needs them.”

The American College of Obstetricians and Gynecologists recognizes boric acid as a second-line option in its clinical guidelines for managing vaginitis in non-pregnant women. The Centers for Disease Control and Prevention also supports boric acid efficacy in managing recurrent Vulvovaginal candidiasis (VVC) with 600 mg of BAS administered vaginally in the same population.

“Evaluating boric acid suppositories for therapeutic use addresses a decades-long gap in clinical evidence and could prove groundbreaking for women’s health,” noted Aparna D. Shah, MD, FACOG, board certified in OB/GYN and urogynecology. “The rigorous design of this randomized, placebo-controlled, double-blinded Phase 3 study focuses on the impact of locally administered boric acid for the treatment of vaginal yeast infections in women. We expect this research on safety and efficacy to help further demonstrate the therapeutic potential of boric acid as a locally administered drug.”

Enrollment for the Phase 3 study has begun at nearly 20 trial sites nationwide. The study is anticipated to be completed in June 2026. See ClinicalTrials.Gov.

About pH-D Feminine Health

Female owned and operated since 2014, pH-D Feminine Health has pioneered boric acid suppository products. The pH-D boric acid vaginal suppository is an investigational product and has not been approved by the U.S. Food and Drug Administration for the treatment, cure, or prevention of vulvovaginal candidiasis. The company’s retail products continue to be available online and nationwide. Co-founder Deeannah Seymour is a Forbes 50 Over 50: Innovation 2025 and an INC. 5000 recipient. Visit https://www.phdfemininehealth.com. Follow @phdfemininehealth. 

Contact: Kellee Johnson for pH-D Feminine Health, 312-751-3959, kmjohnson@ballastgroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ph-d-feminine-health-launches-first-fda-cleared-phase-3-clinical-trial-for-boric-acid-suppositories-302528102.html

SOURCE pH-D Feminine Health